Combating COVID-19

About this fund

The pandemic is not over. Controlling COVID-19 means getting vaccines to everyone, everywhere, while meeting basic human needs like access to medical oxygen and expediting innovations in testing and treatments.

The impact you’ve helped influence


4,455 diagnostics instruments have been sent to 40 countries around the world, expanding testing capabilities for COVID-19.


The Therapeutics Accelerator has supported 13 clinical trials on vaccines and treatments, spanning over 15 countries and three continents.


Gates Philanthropy Partners received more than $100 million from donors like you in 2020. In total we had 5,120 donors, a 137% increase from 2017.


In the hunt to find an effective treatment against COVID-19, scientists analyzed more than 10,000 compounds to find a match.

Preventing and treating COVID-19 will save millions of lives.

Photo by Geert Vanden Wijngaert/Bloomberg via Getty Images


The world needs more than great science to beat this pandemic: it needs great compassion.

Combating COVID-19 allocated funds for 2020 (US$)

COVID-19 is not just a health emergency; it is a social and economic crisis. Beyond developing and delivering vaccines and treatments, we are getting funds to communities to meet basic needs.

A pie chart divided into three unequal sections and labelled A, B and C.  In terms of size, section C is the largest section by far, while B is slightly larger than A.
  1. Diagnostics — $3.40M

  2. Protecting the Most Vulnerable — $4.30M

  3. COVID-19 Therapeutics Accelerator — $66.58M

Unsupported browser detected

Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.

Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.